A number of updates have been made regarding
Becton, Dickinson and Company (BDX). Several investment firms, including Rathbones Group PLC, Forsta AP Fonden, and others have divested a portion of their BDX shares, while DekaBank Deutsche Girozentrale, Vest Financial LLC, and Varma Mutual Pension Insurance Co have bolstered their positions. The firm has also finalized their acquisition of the
Critical Care division from Edwards Lifesciences. The company is being recognized as a strong value and growth stock, and its Q3 earnings have surpassed expectations. Despite this, some hold concerns about the company's debt levels and recent decline in short interest. Nonetheless, BDX still holds a consensus rating of \"Moderate Buy\" from financial analysts. The company also announced a change in leadership, with Michael Feld set to take over as President of the Life Sciences Segment. It further celebrated 75 years of U.S manufacturing in Nebraska and announced its commitment to reduce Scope 1 and 2 emissions.
Becton Dickinson and BDX News Analytics from Thu, 09 Nov 2023 08:00:00 GMT to Sun, 15 Sep 2024 14:11:26 GMT -
Rating 6
- Innovation 4
- Information 8
- Rumor 5
